annamycin has been researched along with Leukemia P388 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ling, YH; Perez-Soler, R; Priebe, W; Van, NT; Zou, Y | 1 |
Burke, TG; Ling, YH; Perez-Soler, R; Pommier, Y; Priebe, W; Yang, LY | 1 |
Ling, YH; Perez-Soler, R; Priebe, W | 1 |
3 other study(ies) available for annamycin and Leukemia P388
Article | Year |
---|---|
Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Chemical Phenomena; Chemistry, Physical; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; KB Cells; Leukemia P388; Liposomes; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Phenotype; Tumor Cells, Cultured | 1994 |
In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.
Topics: Animals; DNA Damage; DNA, Neoplasm; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; In Vitro Techniques; Leukemia P388; Mice | 1993 |
Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Calcium; Cell Membrane; Cycloheximide; Dactinomycin; DNA Damage; Doxorubicin; Drug Resistance; Leukemia P388; Mice; Tumor Cells, Cultured | 1993 |